HTTP/1.1 200 OK
Date: Wed, 12 Feb 2025 14:00:54 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 11444
Connection: keep-alive
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Set-Cookie: SESSID=f8d7b0a8-8397-4f2e-b5ef-425aed88f582; Path=/; SameSite=Lax; HttpOnly; Secure
X-Frame-Options: DENY
Strict-Transport-Security: max-age=31536000;
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-inline'; img-src * data:; style-src 'self' 'unsafe-inline';
SSL Certificate
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
64:9d:3f:3b:d0:a3:db:10:ab:ea:80:57:90:05:41:e3
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=GB, ST=Greater Manchester, L=Salford, O=Sectigo Limited, CN=Sectigo RSA Domain Validation Secure Server CA
Validity
Not Before: Aug 8 00:00:00 2024 GMT
Not After : Sep 8 23:59:59 2025 GMT
Subject: CN=gp.novabiotics.co.uk
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:b6:cd:41:55:10:00:dd:d1:3b:93:3c:a3:89:a3:
d0:5c:17:2e:02:81:d6:12:9b:32:d9:59:58:d3:f0:
82:a6:ba:b8:0a:54:97:b2:29:74:55:0a:04:21:b0:
ea:44:db:94:ba:f7:4a:e6:10:27:be:b6:de:1c:40:
59:87:35:9a:21:6e:ef:5b:3c:5b:94:df:df:c1:11:
11:94:a3:31:dc:7d:4d:7a:7e:54:69:a1:18:c9:a1:
34:a0:b0:8d:09:b0:b2:0e:d2:dc:82:6f:27:4a:f6:
25:53:a7:e5:e8:73:5c:65:e6:1a:18:47:ed:03:ad:
35:a0:12:15:2c:53:1b:27:21:0f:4b:a3:ec:e0:cb:
39:03:68:54:cc:cc:dc:62:62:15:16:c4:58:c6:e8:
54:b9:b8:6a:62:98:df:5a:93:7f:df:3c:7f:82:b3:
ba:9e:82:21:7a:b7:8b:06:b9:c7:64:c4:1c:51:51:
91:c1:6f:5c:86:7c:7a:0d:dc:fd:09:fe:ea:8f:46:
d7:e3:08:30:bf:59:a8:13:c8:3a:8b:a1:86:97:46:
e9:cf:5f:fe:64:f4:2c:24:80:35:63:2f:f1:1b:06:
ad:0e:cb:ae:f3:d9:07:49:c2:26:d3:7b:9a:58:b7:
a9:6a:bb:e5:37:dd:16:b2:73:b4:19:b0:31:bd:0c:
e5:d9
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
X509v3 Subject Key Identifier:
F9:FB:9C:5B:A9:E1:39:4A:6E:7D:2F:42:22:CC:71:5C:52:7F:00:92
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Basic Constraints: critical
CA:FALSE
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Certificate Policies:
Policy: 1.3.6.1.4.1.6449.1.2.2.7
CPS: https://sectigo.com/CPS
Policy: 2.23.140.1.2.1
Authority Information Access:
CA Issuers - URI:http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
OCSP - URI:http://ocsp.sectigo.com
X509v3 Subject Alternative Name:
DNS:gp.novabiotics.co.uk, DNS:www.gp.novabiotics.co.uk
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : DD:DC:CA:34:95:D7:E1:16:05:E7:95:32:FA:C7:9F:F8:
3D:1C:50:DF:DB:00:3A:14:12:76:0A:2C:AC:BB:C8:2A
Timestamp : Aug 8 16:34:43.034 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:21:00:C7:44:65:80:0F:7C:22:E4:6E:9C:4D:
F2:3A:C5:9A:CD:56:3A:F9:99:92:7F:62:EA:39:C9:FC:
DE:06:E9:EB:7D:02:20:3F:8B:3E:92:49:51:C7:88:13:
0A:F6:3A:9E:D0:17:AF:B0:93:2C:07:13:94:0F:55:D9:
39:C0:C8:0F:E4:D4:BB
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 0D:E1:F2:30:2B:D3:0D:C1:40:62:12:09:EA:55:2E:FC:
47:74:7C:B1:D7:E9:30:EF:0E:42:1E:B4:7E:4E:AA:34
Timestamp : Aug 8 16:34:42.937 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:46:02:21:00:AD:FA:B9:CC:62:E5:84:FD:EE:AE:37:
3E:54:58:87:E6:99:55:DF:7B:8F:4B:0E:86:66:1B:EB:
16:89:BD:7E:8A:02:21:00:D6:19:3C:F2:83:61:8B:D5:
13:F4:8A:03:5D:AF:E2:29:BC:F3:A1:1B:DC:2F:45:82:
69:B8:75:7E:47:B2:62:21
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 12:F1:4E:34:BD:53:72:4C:84:06:19:C3:8F:3F:7A:13:
F8:E7:B5:62:87:88:9C:6D:30:05:84:EB:E5:86:26:3A
Timestamp : Aug 8 16:34:42.936 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:09:CD:1F:10:A6:B2:50:17:50:B6:AF:1D:
56:B4:3C:F6:6D:1C:69:72:1A:CF:D6:35:97:E7:C2:95:
0A:6A:DC:E9:02:20:3C:32:50:32:E7:D6:46:B6:73:7C:
64:6A:09:35:6B:CD:6F:95:54:0F:69:86:BF:8C:36:FA:
C0:87:14:00:B8:C6
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
94:39:5f:43:42:b3:eb:4c:82:7b:75:c9:0e:90:32:3d:1b:4c:
42:a1:84:b5:e5:2d:0a:53:31:fc:3b:33:62:9a:f6:e8:b1:96:
3d:4f:b1:60:64:8f:72:ae:1e:74:b8:15:8a:01:02:93:71:7c:
40:29:69:e5:72:4d:aa:f6:46:9c:e1:b1:45:df:e2:e6:97:b9:
18:da:6f:2b:65:31:a1:15:fa:0a:a6:68:52:a9:71:82:ff:29:
8b:f7:a0:fd:b2:35:b0:bb:3a:ef:bf:35:36:99:a4:54:fd:78:
97:ca:3b:a3:c7:e8:b5:9e:2d:8d:61:1c:53:1f:3c:16:a4:5a:
6e:8a:6b:ec:54:ee:fc:00:62:be:dc:23:a0:97:cf:7d:e1:66:
7b:46:b5:d4:71:49:98:4b:c0:af:03:c8:21:36:96:82:8f:34:
f5:ea:5c:10:9e:b5:2c:be:1a:53:57:d5:5c:7c:b2:de:66:d6:
4e:07:75:e1:19:f2:f5:7c:09:e3:d4:a1:d8:5b:90:eb:1a:d2:
ad:ac:09:fb:5e:dc:96:b8:2f:ba:76:80:98:a2:43:20:5a:4b:
85:b7:8c:e8:8a:0b:9d:c5:5a:d0:b7:73:c5:df:91:9d:97:3c:
ab:57:b5:a1:db:ee:d5:ca:f2:c3:ce:84:1d:a5:65:8e:85:5a:
ab:5b:00:c5